The effect of naltrexone in lichen planopilaris
Phase 2
Recruiting
- Conditions
- ichen Planopilaris.Lichen planopilaris
- Registration Number
- IRCT20180809040747N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 34
Inclusion Criteria
Diagnosis of Lichenplanopilaris (LPP) based on pathology
Exclusion Criteria
Burn-out lesions
Any treatments for lichenplanopilaris within the last month
History of drug addiction or alcohol abuse
History of psychiatric disorders
Willing to get or being pregnant
Consumption of drugs interfering with naltrexone (e.g. opioid antagonists)
Generalized cutaneous or mucosal lichen plan
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ichen Planopilaris Acivity Index (LPPAI) Score. Timepoint: before intervention and 2, 4 , 6 months after intervention. Method of measurement: LPPAI Questionnair.
- Secondary Outcome Measures
Name Time Method Treatment tolerance. Timepoint: 2, 4 and 6 months after intervention. Method of measurement: Interview.;ESR. Timepoint: Before intervention and 2, 4 and 6 months after intervention. Method of measurement: Lab kit.